ADIPOQ and metabolic syndrome: In the case–control study, which included 809 participants where, besides control groups, participants had been classified according to the presence of MetS, T2DM, or both diseases, the AR index appeared to statistically significantly correlate with markers of MetS and T2DM and MetS rather than adiponectin and resistin levels alone [14].